1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
Biopsy Device Market: Needles Product Type Segment Anticipated to Retain Its Dominance Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026

Biopsy Device Market: Needles Product Type Segment Anticipated to Retain Its Dominance Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026

  • January 2017
  • 277 pages
  • ID: 4715258
  • Format: PDF
  • By Future Market Insight Global & Consulting Pvt Ltd

Summary

Table of Contents


Government initiatives in cancer treatment to fuel growth of the global biopsy device market during the projected period

Global demand for biopsy devices is increasing, supported by rising incidence of cancer. Future Market Insights presents in-depth analysis of the global biopsy device market for the forecast period, 2016–2026. Revenue from the global biopsy device market is expected to register a CAGR of 6.5% during the assessment period and is expected to be valued at nearly US$ 2,700 Mn by 2026 end.

Increasing incidence of cancer and favourable reimbursement programs are factors expected to drive revenue growth of the global biopsy device market during the assessment period

The guidance system segment was estimated to account for 16.1% revenue share of the global biopsy device market by 2016 end and is expected to gain 222 BPS in market share by 2026 over 2016, owing to an increase in the awareness of early detection of breast cancer.

The needles segment was estimated to account for 37.6% revenue share of the global biopsy device market by 2016 end and is expected to lose 125 BPS in market share by 2026 over 2016. The segment is expected to reach nearly US$ 960 Mn by 2026 owing to an increasing awareness among people regarding the early detection of cancer.

Global Biopsy Device Market Absolute $ Opportunity by Product Type, 2016–2026
- Guidance system segment is estimated to create absolute $ opportunity of more than US$ 15 Mn in 2017 over 2016. Revenue from guidance system segment is anticipated to register a CAGR of 7.9% over 2016–2026, to reach more than US$ 480 Mn towards the close of the forecast period
- Biopsy needles segment is estimated to create absolute $ opportunity of nearly US$ 30 Mn in 2017 over 2016. Revenue from biopsy needles segment is anticipated to register a CAGR of 6.2% over 2016–2026, to reach nearly US$ 960 Mn by 2026 end
- Guns segment is estimated to create absolute $ opportunity of nearly US$ 25 Mn in 2017 over 2016. Revenue from guns segment is anticipated to witness a CAGR of 6.8% over 2016–2026, to reach more than US$ 700 Mn towards the close of 2026
- Reagents and kits segment is estimated to create absolute $ opportunity of more than US$ 3 Mn in 2017 over 2016. Revenue from reagents and kits segment is anticipated to witness a CAGR of 6.4% over 2016–2026, to reach nearly US$ 120 Mn at the end of the assessment period
- Others (Brushes, Curettes and Punches etc.) segment is estimated to create absolute $ opportunity of nearly US$ 10 Mn in 2017 over 2016. Revenue from Others segment is anticipated to witness a CAGR of 5.3% over 2016–2026, to reach more than US$ 360 Mn by 2026 end

Global Biopsy Device Market Attractiveness Analysis by Product Type, 2016–2026
Needles segment dominated the global biopsy device market in revenue terms in 2015 and is projected to continue to do so throughout the forecast period. Needles segment is the most attractive segment, with a market attractiveness index of 1.8 over the forecast period. The segment accounted for 37.7% value share in 2016 and is projected to account for 36.5% share by 2026 end. Guns segment is expected to be the second most lucrative segment in the global biopsy device market, with a market attractiveness index of 1.3 during the forecast period. The increasing requirement for more advanced and innovative technology products in the field of biopsy and growing usage of biopsy needles makes it the most attractive segment in the global biopsy device market. Companies operating in the global biopsy device market are actively engaged in mergers, acquisitions and partnerships to capture a larger share of the market in the near future

The global biopsy device market is a fragmented market with about 69% market share contributed by CR Bard, Becton, Dickinson and Company, B. Braun Melsungen AG, Hologic, Inc., Cook Medical, Devicor Medical Products Inc. and Argon Medical Inc. Companies are entering into strategic mergers and acquisitions to improve their biopsy device product portfolio and are focussing on distributional agreements to overcome issues related to product availability in various geographical areas.

Analyst Viewpoint

“In the coming decade, liquid biopsy procedure is likely to pose a major threat to the biopsy device market”

Liquid biopsy offers non-invasive diagnostic tests for detecting cancer as it provides a simple, relatively less expensive blood, urine or plasma test to detect malignancy in any part of the patient’s body. Liquid biopsy is expected to provide a better sample for any type of diagnosis and analysis as it can be taken repeatedly. This overcomes the challenge associated with repeated tissue samples. Liquid samples help detect disease progression in real time, predict outcomes and switch treatment when required and potentially increase the life expectancy of the patient. Thus, liquid biopsy procedure is likely to be a major threat to the global biopsy device market in the coming decade.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

($5000)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Smart Biopsy Market (2019-2025)

Global Smart Biopsy Market (2019-2025)

  • $ 3600
  • November 2019

The Global Smart Biopsy Market size is expected to reach $3.2 billion by 2025, rising at a market growth of 5.3% CAGR during the forecast period. A biopsy is referred to as the surgical removal of tissue ...

North America Hereditary Cancer Testing Market to 2027 - Regional Analysis and Forecasts by Diagnosis Type; Technology; End User, and Country

North America Hereditary Cancer Testing Market to 2027 - Regional Analysis and Forecasts by Diagnosis Type; Technology; End User, and Country

  • $ 3000
  • October 2019

The North America hereditary cancer testing market is expected to reach US$ 3,247.37 Mn in 2027 from US$ 1,255.79 Mn in 2018. This market is projected to grow at a growth rate of 11.6% from 2019-2027.The ...

Breath Biopsies: A Revolutionary Approach for Noninvasive Diagnosis

Breath Biopsies: A Revolutionary Approach for Noninvasive Diagnosis

  • $ 2500
  • September 2019

Report Includes:- Detailed discussion on breath as a snapshot of an individuals’ health- Assessment of the role of breath biopsy in drug development, diagnosis and treatment of respiratory diseases, ...


ref:plp2017

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on